Stem-Cells: To Patent or Not?

In spare moments, I’ve been wondering about the Advocate-General of European Court of Justice’s recent recommendation that patents involving human embryonic stem-cells be prohibited, and the response that it’s generated.  One of the best-publicised responses was the letter from Austin Smith et al that appeared in Nature, which complained that the recommendation would be bad […]

Read More…

Hyperexpensive royal weddings – the opportunity costs in terms of health

By David Hunter James Wilson (UCL) and I recently wrote a briefing paper for the Nuffield Council on Bioethics on the ethical issues surrounding hyper-expensive treatments – that is treatments which exceed NICEs usual cut off point of £30000 per quality adjusted life year (qualy). One factor that we kept coming back to was the […]

Read More…

Conference: Global Health, Global Goods, and International Community

Public Lecture and Two Day Conference 1-3 June 2011 Institute for Science, Ethics and Innovation, The University of Manchester The two-day conference will focus on issues in global health and questions concerning shared commitments within the international community. It will bring together leading experts from academia and policy, representing a broad diversity of disciplinary backgrounds […]

Read More…

Consultation: Emerging Biotechnologies

The Nuffield Council on Bioethics has announced that it has opened a consultation on emerging biotechnologies: The Council is seeking views on the ethical issues posed by emerging biotechnologies. Your views will be valuable in shaping and informing the deliberations of a Working Party that was recently set up to consider this topic. The Working Party […]

Read More…